Metraipolis › archive › dc_ebdfeee0fadc
Engineered nanocarriers for targeted lung cancer therapy: mechanistic innovations and recent clinical progress — Europe PMC PMID:41113763
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41113763
- DOI
- 10.37349/etat.2025.1002339
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T09:36:00.358Z
- SHA-256 of the archived text
3b3a87023ec5e032a24f27eea0f3f1f3c3f97e7017e9c669743b4a28546f392a- Stable URL of this page
https://metraipolis.com/documento/dc_ebdfeee0fadc
How to cite
Engineered nanocarriers for targeted lung cancer therapy: mechanistic innovations and recent clinical progress — Europe PMC PMID:41113763 — Europe PMC (en), https://europepmc.org/article/MED/41113763 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ebdfeee0fadc (Metraipolis archive dc_ebdfeee0fadc, sha256 3b3a87023ec5e032a24f27eea0f3f1f3c3f97e7017e9c669743b4a28546f392a)
BibTeX
@misc{dcebdfeee0fadc,
title = {Engineered nanocarriers for targeted lung cancer therapy: mechanistic innovations and recent clinical progress — Europe PMC PMID:41113763},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41113763},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ebdfeee0fadc; sha256 3b3a87023ec5e032a24f27eea0f3f1f3c3f97e7017e9c669743b4a28546f392a},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41113763. Agents can read the archived copy with the MCP tool read_document.